Abstract
The use of CRISPR/Cas genome editing in agriculture and medicine develops in a state of vagueness regarding regulation, trust and responsible research. The precautionary principle could provide a way for handling these uncertainties when developing safe and socially acceptable applications.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Ethics, Research*
-
Gene Editing*
-
Genomics / ethics*
-
Genomics / legislation & jurisprudence
-
Humans
-
Research